古风小说,小说阅读器

異檸檬酸脫氫酶1(IDH1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)

ELISA Kit DIY Materials for Isocitrate Dehydrogenase 1, Soluble (IDH1)

PICD; IDP; Oxalosuccinate decarboxylase; NADP(+)-specific ICDH; Cytosolic NADP-isocitrate dehydrogenase

酶與激酶

編號KSH839Hu01
物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 所有
- 人
- 小鼠
- 大鼠
- 豚鼠
- 家兔
- 獼猴
- 山羊
- 綿羊
- 馬
- 牛
- 豬
- 雞
- 狗
- 其他物種
- 多物種
- 泛物種
試劑內(nèi)容 包被抗體、檢測抗體、標(biāo)準(zhǔn)品、HRP標(biāo)記的鏈霉親和素、TMB底物、96孔板
可檢測樣本Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
可適用原理雙抗夾心酶聯(lián)免疫吸附試驗法測抗原
可檢測范圍0.781-50ng/mL
可適靈敏度0.37ng/mL
應(yīng)用Main materials for "Do It (ELISA Kit) Yourself".
下載英文說明書中文說明書
規(guī)格 96T*596T*10 96T*20 96T*50 96T*100
價格 ¥ 7560 12600 ¥ 12600 ¥ 22680 ¥ 44100 ¥ 75600
欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!

產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)

通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

試劑盒中的抗體對異檸檬酸脫氫酶1(IDH1)具有高靈敏度和高特異性，經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。

用法

1.用100μL每孔的工作濃度的包被抗體包被96孔板，4度孵育過夜或者37度孵育2小時；
2.洗板1次；
3.用200μL每孔的工作濃度的封閉液,37度孵育1.5小時；
4.洗板1次。酶標(biāo)板即可用于ELISA實驗，后續(xù)使用方法與ELISA同。

儲存

抗體，標(biāo)準(zhǔn)品和HRP標(biāo)記的鏈霉親和素在-20度保存，TMB需在4度保存，96孔板在室溫保存。所有組分保質(zhì)期為1年，試劑一旦開封，在4度保存時間為1個月。

配套試劑

贈品

ELISA/CLIA實驗服務(wù)

增值服務(wù)

化學(xué)發(fā)光試劑盒定制服務(wù)
酶聯(lián)免疫試劑盒定制服務(wù)
檢測試劑盒DIY輔助試劑包1
檢測試劑盒DIY輔助試劑包2
標(biāo)準(zhǔn)品稀釋液
 包被緩沖液
 抗體稀釋緩沖液
 檢測試劑盒DIY輔助試劑包3
檢測試劑盒DIY輔助試劑包4
實時熒光定量PCR實驗服務(wù)

相關(guān)產(chǎn)品

編號	適用物種：Homo sapiens (Human，人)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPH839Hu01	異檸檬酸脫氫酶1(IDH1)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
PAH839Hu01	異檸檬酸脫氫酶1(IDH1)多克隆抗體	WB,IHC
FAH839Hu01	抗異檸檬酸脫氫酶1(IDH1)多克隆抗體	Flow cytometry.
MAH839Hu22	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC
MAH839Hu23	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
MAH839Hu25	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
MAH839Hu27	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
MAH839Hu29	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
MAH839Hu24	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC
MAH839Hu26	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC
MAH839Hu21	異檸檬酸脫氫酶1(IDH1)單克隆抗體	WB; IHC; ICC; IP.
RAH839Hu21	異檸檬酸脫氫酶1(IDH1)重組抗體	WB; IFC; IHC; IP.
FAH839Hu02	抗異檸檬酸脫氫酶1(IDH1)單克隆抗體	Flow cytometry.
FAH839Hu04	抗異檸檬酸脫氫酶1(IDH1)單克隆抗體	Flow cytometry.
FAH839Hu06	抗異檸檬酸脫氫酶1(IDH1)單克隆抗體	Flow cytometry.
FAH839Hu08	抗異檸檬酸脫氫酶1(IDH1)單克隆抗體	Flow cytometry.
LAH839Hu76	異檸檬酸脫氫酶1(IDH1)單克隆抗體(生物素標(biāo)記)	WB; IHC; ICC.
IEH839Hu	異檸檬酸脫氫酶1(IDH1)檢測試劑盒(酶聯(lián)免疫吸附試驗法,快捷型)	Enzyme-linked immunosorbent assay for Antigen Detection.
SEH839Hu	異檸檬酸脫氫酶1(IDH1)檢測試劑盒(酶聯(lián)免疫吸附試驗法)	Enzyme-linked immunosorbent assay for Antigen Detection.
SCH839Hu	異檸檬酸脫氫酶1(IDH1)檢測試劑盒(化學(xué)發(fā)光免疫分析法)	Chemiluminescent immunoassay for Antigen Detection.
LMH839Hu	異檸檬酸脫氫酶1(IDH1)等多因子檢測試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.
PSH839Hu01	異檸檬酸脫氫酶1(IDH1)抗體對	ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSH839Hu01	異檸檬酸脫氫酶1(IDH1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)	Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志	參考文獻(xiàn)
Molecular & Cellular Proteomics	Identification of IDH1 as a Potential Diagnostic and Prognostic Biomarker for Non-small-cell Lung Cancer by Proteomic Analysis [Mcponline: 008821]
Molecular & Cellular Proteomics	Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis [Pubmed: 22064513]
Clinical Cancer Research	Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer [Pubmed: 24046070]
Onco Targets Ther	The effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cells [PubMed: 25914546]
Oncogene	Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism [Pubmed:29921847]
Molecular Oncology	IDH 2 is a novel diagnostic and prognostic serum biomarker for non‐small‐cell lung cancer [Pubmed:29465809]
Cancers	Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver … [Pubmed: 32443439]
International Journal of Cancer	Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer [Pubmed:35689436]

留言咨詢